168
Participants
Start Date
October 31, 2003
Primary Completion Date
June 30, 2007
Study Completion Date
November 30, 2007
rituximab
Dose, schedule,and duration specified in protocol
Our Lady of Mercy Medical Center, The Bronx
University of Pittsburth Cancer Centers, Pittsburgh
Carle Clinic Association, Urbana
USC KECK School of Medicine, Los Angeles
Radiant Research, Honolulu
Tufts - New England Medical Center, Boston
University of Texas Health Science Center at San Antonio, San Antonio
Research Site, Graz
Research Site, Brno
Research Site, Hradec Králové
Research Site, Olomouc
Research Site, Prague
Research Site, Dijon
Research Site, Lyon
Research Site, Paris
Research Site, Strasbourg
Research Site, Berlin
Research Site, Bonn
Research Site, Frankfurt
Research Site, Giessen
Research Site, Hamburg
Research Site, Koblenz
Research Site, Mainz
Research Site, Mutlangen
Research Site, Tübingen
Research Site, Kaunas
Research Site, Klaipėda
Research Site, Vilnius
Research Site, Brasov
Research Site, Bucharest
Research Site, Cluj-Napoca
Research Site, Craiova
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Obninsk
Research Site, Saint Petersburg
Research Site, Yekaterinburg
Research Site, Stockholm
Research Site, Gaziantep
Research Site, Izmir
Research Site, Kayseri
Research Site, Leeds
Research Site, Leicester
Research Site, Manchester
Research Site, Sheffield
Lead Sponsor
Biogen
INDUSTRY